Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 22/11/2020
SIETES contiene 93161 citas

 
 
 1 a 20 de 50 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Zhu H, Bateman BT, Gray KJ, Hernandez-Diaz S, Mogun H, Starub L, Huybrechts KF. Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study. BMJ 2020;369:20 de mayo. [Ref.ID 103628]
2. Cita con resumen
Blotière P-O, Raguideau F, Weill A, Elefant E, Perthus I, Goulet V, Rouget F, Zureik M, Coste J, Dray-Spira R. Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs. Neurology 2019;93:. [Ref.ID 103248]
3.Enlace a cita originalTiene citas relacionadas Cita con resumen
Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med 2018;381:29 de agosto. [Ref.ID 102748]
4.Tiene citas relacionadas Cita con resumen
Rasmussen SA, Barfield W, Honein MA. Protecting mothers and babies — A delicate balancing act. N Engl J Med 2018:24 de julio. [Ref.ID 102747]
6.Enlace a cita original Cita con resumen
Bergman JEH, Lutke LR, Gans ROB, Addor M-C, Barisic I, Clavero-Carbonell C, Garne E, Gatt M, Klungsoyr K, Lelong N, Lynch C, Mokoroa O, Nelen V, Neville AJ, Pierini A, Randrianaivo H, Rißmann A, Tucker D, Wiesel A, Dolk H, Loane M, Bakker MK. Beta-blocker use in pregnancy and risk of specific congenital anomalies: A European case-malformed control study. Drug Saf 2018;41:415-27. [Ref.ID 102566]
8. Cita con resumen
Anónimo. Topiramate approved for migraine prevention in adolescents. U.S. Food and Drug Administration 2014:28 de marzo. [Ref.ID 97390]
9. Cita con resumen
Pastemak B, Svanström H, Molgaard-Nielsen D, Melbye M, Hviid A. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. JAMA 2013;310:1601-11. [Ref.ID 96391]
10. Cita con resumen
Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA 2013;311:74-86. [Ref.ID 96313]
11. Cita con resumen
Anónimo. New weight-loss drugs and the US obesity epidemic. Lancet 2012;380:308. [Ref.ID 93509]
13.Enlace a cita original Cita con resumen
Anónimo. Change in the pregnancy category for topiramate. Australian Prescriber 2012;35:66. [Ref.ID 93159]
14. Cita con resumen
Anónimo. FDA panel recommends weight-loss drug phentermine/topiramate.. DIA Daily 2012:23 de febrero. [Ref.ID 92163]
16.Tiene citas relacionadas
Tomson T, Battino D, Perucca E. Major birth defects after exposure to newer-generation antiepileptic drugs. JAMA 2011;306:826-7. [Ref.ID 91017]
17.Tiene citas relacionadas
Merry L, Martin KL, Chen T. Major birth defects after exposure to newer-generation antiepileptic drugs. JAMA 2011;306:826. [Ref.ID 91016]
18.Tiene citas relacionadas Cita con resumen
Molgaard-Nielsen D, Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA 2011;305:1996-2002. [Ref.ID 90564]
19.Tiene citas relacionadas Cita con resumen
Nulman I. Levetiracetam and lamotrigine are better options. Author's reply. BMJ 2011;342:243. [Ref.ID 90135]
Seleccionar todas
 
 1 a 20 de 50 siguiente >>